New antibiotic eye drops for drug-resistant eye infections
Part of Brain & nervous system, Eyes & vision, Infections clinical trials.
This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a bacterial eye infection that is resistant to multiple antibiotics.
- You are 18 years or older.
- You do not have an immune system disease affecting your eyes.
- Your eyelids close properly and you can blink normally.
- Your eye structure and function suggest that vision might improve after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an antibiotic injection directly into the cornea can help when standard eye drops are not working for a stubborn bacterial eye infection.
This study looks at whether using a concentrated saltwater solution (5% sodium chloride) along with standard antibiotic eye drops can help treat bacterial eye infections more effectively and speed up recovery.
This study is testing a steroid eye drop (fluorometholone) as an add-on to standard antibiotic treatment for bacterial corneal ulcers. The goal is to see if adding the steroid helps reduce inflammation and improves healing compared to antibiotics alone.
This study tests a new eye drop solution (PRO-240) compared to an existing one (Optive) in healthy adults. It aims to see how safe and comfortable the new drops are for dry eye relief.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Hear when a new Bacterial Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.